| 產品名稱 |
SU-DHL-1 |
| 商品貨號 |
B199815 |
| Organism |
Homo sapiens, human |
| Tissue |
lymph node
Derived from Metastatic Site: peritoneal effusion |
| Cell Type |
histiocytic |
| Product Format |
frozen |
| Morphology |
lymphoblast-like |
| Culture Properties |
suspension |
| Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease |
large cell lymphoma; diffuse histiocytic lymphoma |
| Age |
10 years |
| Gender |
Male |
| Ethnicity |
Caucasian |
| Applications |
The availability of a permanently established human neoplastic cell line as the source of this type C RNA virus should greatly facilitate studies of its biological significance. Evidence has recently been obtained that the virus can induce proliferation of normal human monocytes and histiocytes in vitro. |
| Storage Conditions |
liquid nitrogen vapor phase |
| Karyotype |
88 chromosomes; t(2;5)(p23;q35) translocation |
| Images |
 |
| Clinical Data |
10 years Caucasian Male |
| Antigen Expression |
Monocyte Marker: CD163+
Lymphoid Marker: CD45-
Progenitor Markers: CD10-, CD34-
Activation Markers: CD30+, CD25+, CD70+, CD71+, CD80-, HLA-DR+, CD45-
T-Cell Markers: CD2-, CD3-, CD4-, CD5+, CD7-, CD8-
B-Cell Markers: CD19-, CD20-, CD21-, CD22-
Myelomonocytic Markers: CD11b-, CD11c-, CD13-, CD14-, CD15-, CD33-
|
| Receptor Expression |
CFS-1 expressed
IL-1-R, IL-2-Rα, IL-6-R, TNFα-R, & c-fms expressed
Surface Receptors: Fc, IgMEAC, IgGEA, & E not expressed |
| Oncogene |
c-fms (proto-oncogene), bcl-6+(c-onc) |
| Genes Expressed |
Fusion gene NPM-ALK (p80)+
anaplastic lymphoma kinase (ALK)+
Ig, not expressed
|
| Comments |
The cells are surface Ig negative (sIG-).
The cells are non-specific esterase, acid phosphatase and oil red O positive.
The cells are periodic acid Schiff negative.
These cells phagocytose Candida albicans and latex particles.
The cells are reported to be very weakly E - rosette positive.
ATCC confirmed this cell line is negative for the presence of Epstein-Barr viral DNA sequences via PCR. |
| Complete Growth Medium |
The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, ATCC 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (ATCC 30-2020) to a final concentration of 10%.
|
| Subculturing |
Cultures can be maintained by the addition of fresh medium. An inoculum of 8.0 x 104 to 2.0 x 105cells/mL is recommended. Subculture when the cell concentration is between 1.0 x 106 and 1.5 x 106 cells/mL.
Subcultivation ratio: A subcultivation ratio of 1:4 to 1:12 is recommended.
Interval: As needed.
Medium renewal: every 2 to 4 days |
| Cryopreservation |
Storage temperature: liquid nitrogen vapor phase Freeze medium: Complete growth medium supplemented with an additional 20% fetal bovine serum and 10% DMSO |
| Culture Conditions |
Temperature: 37.0°C
Atmosphere: air, 95%; carbon dioxide (CO2), 5% |
| STR Profile |
D5S818: 11, 12
D13S317: 9, 13
D7S820: 10, 13
D16S539: 11, 12
vWA: 15, 17
THO1: 6, 7
Amelogenin: X Y
TPOX: 8
CSF1PO: 12 |
| Population Doubling Capacity |
infinite |
| Name of Depositor |
A Epstein |
| References |
Epstein AL, et al. Biology of the human malignant lymphomas. IV. Functional characterization of ten diffuse histiocytic lymphoma cell lines. Cancer. 42(5): 2379-2391, 1978. PubMed: 214220
Siminovitch KA, et al. Immunoglobulin gene rearrangements and expression in diffuse histiocytic lymphomas reveal cellular lineage, molecular defects, and sites of chromosomal translocation. Blood. 67(2): 391-397, 1986. PubMed: 3080039
Epstein AL, Kaplan HS. Feeder layer and nutritional requirements for the establishment and cloning of human malignant lymphoma cell lines. Cancer Res. 39(5):1748-1759, 1979. PubMed: 371794
|